Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas

PURPOSE: Mucinous ovarian carcinomas (MOCs) are relatively rare. It has been proposed that a subset of mucinous cystadenomas (MCAs) may progress to mucinous borderline tumors (MBTs), and then to MOCs. KRAS is the predominantly mutated gene in MOC; however, other associated mutations and the mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnishi, Kaori, Nakayama, Kentaro, Ishikawa, Masako, Ishibashi, Tomoka, Yamashita, Hitomi, Nakamura, Kohei, Minamoto, Toshiko, Iida, Kouji, Razia, Sultana, Ishikawa, Noriyoshi, Kyo, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321901/
https://www.ncbi.nlm.nih.gov/pubmed/32556513
http://dx.doi.org/10.1007/s00404-020-05638-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321901/
https://www.ncbi.nlm.nih.gov/pubmed/32556513
http://dx.doi.org/10.1007/s00404-020-05638-8

Ejemplares similares